Sam Klempner
@klempnersam
GI medical oncologist focusing on stomach and esophageal cancer research at Massachusetts General Hospital, Harvard Medical School
ID: 1086165456757477377
18-01-2019 07:36:39
1,1K Tweet
3,3K Takipçi
664 Takip Edilen
Congratulations to Harsh Singh and Dana-Farber team for getting this data out. CAPOX + Trastuzumab + Bevacizumab in frontline HER2+ gastroesophageal. Nature Communications James Cleary Ronan Kelly and others rdcu.be/dQvh4 -- full paper doi.org/10.1038/s41467…